Galway's Shortcut to Global Success with its Med-Tech Startups
The city's med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough.
Imperial Innovations Group Plc - Uncovering the unquoted potential
Imperial Innovations has made significant progress in continuing not only to create new, exciting and innovative companies, but in nurturing existing companies towards important inflection points.
An interview with Professor Thomas Zeller, MD
The Director of the Department of Angiology at Universitaets-Herzzentrum talks data on renal denervation, drug-eluting balloons, and other recent trials.
3D Helical Stent Twelve Month Data Suggest Correlation between Stented Vessel Curvature and Primary Patency
Data presented here today during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 show that a stent with unique three-dimensional helical geometry, BioMimics 3D™, developed by Veryan Medical Ltd...
Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients
PARIS, France—A “3D” helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results...
Clinical Data Supports Efficacy of New 3-D Stent
On May 21, Veryan Medical Ltd. presented data during the Trials and Innovations for Peripheral Interventions Session at EuroPCR 2013 in Paris, France, on its Biomimics 3D stent. A recent trial has demonstrated safety and promising...
Veryan Medical: Improving Stent Performance with 3-D, Helical Geometry
One of the most interesting emerging competitors in the peripheral vascular stenting space is UK-based Veryan Medical Ltd. The privately held, venture funded company has developed a unique yet straightforward method of producing...
Imperial Innovations Set to Increase Investment in Veryan Medical
The technology transfer, incubation and venture investment company Imperial Innovations, Veryan's largest investor with a 44.3% shareholding, is proposing to increase its investment in the company, in order to help fund future growth...
CX 2016 - Good day for drug-coated balloons, swirling flow stents and drug-eluting stents
Professor Peter Gaines, Sheffield,UK, made the cas for why inducing swirling flow improves the outcome from endovascular procedures..